参考文献/References:
[1] LO M S. A framework for understanding Kawasakidisease pathogenesis [J]. Clin Immunol, 2020, 214:108385.
[2] KAINTH R, SHAH P. Kawasaki disease: origins andevolution[J]. Arch Dis Child, 2019. http://dx.doi.org/10.1136/archdischild-2019-317070.
[3] XIE Liping, YAN Weili, HUANG Min, et al.Epidemiologic features of Kawasaki disease inShanghai from 2013 through 2017 [J]. Journal ofEpidemiology, 2020, 30(10): 429-435.
[4] ELAKABAWI K, LIN Jing, JIAO Fuyong, etal. Kawasaki disease: global burden and geneticbackground [J]. Cardiology Research, 2020, 11(1):9-14.
[5] CHEN Shaojie, DONG Ying, KIUCHI M G, et al.Coronary artery complication in Kawasaki diseaseand the importance of early intervention a systematicreview and meta-analysis[J]. JAMA Pediatrics, 2016,170(12): 1156-1163.
[6] KAWAMURA Y, TAKESHITA S, KANAI T, et al. Thecombined usefulness of the neutrophil-to-lymphocyteand platelet-to-lymphocyte ratios in predictingintravenous immunoglobulin resistance with KawasakiDisease[J]. J Pediatr, 2016, 178: 281-284, e1.
[7] BEHMADI M, ALIZADEH B, MALEK A. Comparisonof clinical symptoms and cardiac lesions in childrenwith typical and atypical Kawasaki Disease[J]. MedicalSciences (Basel, Switzerland), 2019, 7(4): 63.
[8] MCCRINDLE B W, ROWLEY A H, NEWBURGERJ W, et al. Diagnosis, treatment, and Long-Termmanagement of Kawasaki disease: a scientificstatement for health professionals from the Americanheart association[J]. Circulation, 2017, 135(17):e927-e999.
[9] NOVAL RIVAS MN, ARDITI M. Kawasakidisease: pathophysiology and insights from mousemodels[J]. Nature Reviews Rheumatology, 2020,16(Suppl1):391-405.
[10] MOUSSA T, WAGNER-WEINER L. Kawasakidisease: beyond IVIG and aspirin[J]. Pediatric Annals,2019, 48(10): e400-e405.
[11] SON MARY B F, GAUVREAU K, TREMOULET AH, et al. Risk model development and validation forprediction of coronary artery aneurysms in KawasakiDisease in a North American population[J].Journal of the American Heart Association, 2019,8(11):e011319.
[12] QIAN Weiguo, TANG Yunjia, YAN Wenhua, et al.A comparison of efficacy of six prediction modelsfor intravenous immunoglobulin resistance inKawasaki disease[J]. Italian Journal of Pediatrics,2018, 44(1): 33.
[13] CAN E, CAN C. The value of neutrophil-to-lymphocyteratio (NLR) and platelet-to-lymphocyte ratio (PLR)parameters in analysis with fetal malnutritionneonates[J]. Journal of Perinatal Medicine, 2019, 47(7):775-779.
[14] QIN Baodong, MA Ning, TANG Qingqin, et al.Neutrophil to lymphocyte ratio (NLR) and plateletto lymphocyte ratio (PLR) were useful markers inassessment of inflammatory response and diseaseactivity in SLE patients[J]. Modern Rheumatology,2016, 26(3): 372-376.
[15] KAPLAN M, ATES I, OZTAS E, et al. A new markerto determine prognosis of acute pancreatitis: PLR and NLR combination[J]. Journal of Medical Biochemistry,2018, 37(1): 21-30.
[16] LIU Xiaoliang, ZHOU Kaiyu, HUA Yimin, et al.Prospective evaluation of neutrophil-to-lymphocyteratio and platelet-to-lymphocyte ratio for intravenousimmunoglobulin resistance in a large cohort ofkawasaki disease patients[J]. Pediatric InfectiousDisease Journal, 2020, 39(3): 229-231.
[17] 袁迎第 , 孙军 , 魏春雷 . 中性粒细胞与淋巴细胞比值对川崎病患儿冠状动脉扩张的预测作用 [J]. 中华实用儿科临床杂志 , 2017, 32（21）:1661-1664．YUAN Yingdi，SUN Jun，WEI Chunlei. The useful-ness of neutrophil-to-lymphocyte ratio in predictingcoronary artery dilation with Kawasaki disease [J].Chin J Appl Clin Pediatr, 2017,32(21): 1661-1664.
[18] 陈利涛．中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值在预测川崎病免疫球蛋白敏感性中的价值研究 [J]. 全科医学临床与教育 ,2019,17（7）:616-618, 622．CHEN Litao. Values of neutrophil to lymphocyte ratio,platelet to lymphocyte ratio in predicting the sensitivityof immunoglobulin to Kawasaki disease [J]. ClinicalEducation of General Practice, 2019, 17 (7): 616-618,622.
[19] 袁迎第 , 孙军 , 李鹏飞 , 等 . 中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对于川崎病 IVIG 敏感性的预测价值[J].中国当代儿科杂志, 2017, 19 (4):410-413.YUAN Yingdi, SUN Jun, LI Pengfei, et al. Values ofneutrophil-lymphocyte ratio and platelet-lymphocyteratio in predicting sensitivity to intravenousimmunoglobulin in Kawasaki disease[J]. Chin JContemp Pediatr, 2017, 19 (4): 410-413.
[20] CHEN Yongbing ,HUA Ying, ZHANG Chunyu,etal.Neutrophil-to-lymphocyte ratio predicts intravenousimmunoglobulin-resistance in infants under 12-monthsold with Kawasaki disease[J]. Frontiers in Pediatrics,2019, 7: 81.
[21] 王策 , 于宪一 .320 例川崎病患儿临床特点及冠状动脉损伤的高危因素分析 [J]. 中国小儿急救医学 ,2018, 25（12）: 939-942, 947．WANG Ce, YU Xianyi. Clinical characteristics andrisk factors of coronary artery abnormities in 320children with Kawasaki disease[J]. Chinese PediatricEmergency Medicine, 2018, 25 (12): 939-942,947.
相似文献/References:
[1]盛伟武,高春彪,管华玲.miRNA-145和miRNA-143在川崎病患儿血浆中的表达及意义[J].现代检验医学杂志,2016,31(05):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
SHENG Wei-wu,GAO Chun-biao,GUAN Hua-ling.Expression and Its Significance of MicroRNA-145 and
MicroRNA-143 in Plasma in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2016,31(06):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
[2]靳剑芸,李启亮,宋文琪.血浆血栓弹力图与抗凝血酶Ⅲ检测对儿童川崎病诊断的应用价值[J].现代检验医学杂志,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
JIN Jian-yun,LI Qi-liang,SONG Wen-qi.Correlation Discussion of Blood Plasma Thromboelastography
Values and Antithrombin III Level in Children's Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2017,32(06):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]刘丽莎,李喆倩,谈 诚,等.川崎病并发冠脉损伤患儿血清活化HUVECs NF-κB促使MMP-9 mRNA水平上调的实验研究[J].现代检验医学杂志,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
LIU Li-sha,LI Zhe-qian,TAN Cheng,et al.Experimental Study on the Up-Regulation of NF- kappa B
and MMP-9 mRNA Level in HUVECs Stimulated by Serum from Children
with Coronary Artery Lesions of Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2018,33(06):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[4]李俏,张李钰,赵传梅,等.西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J].现代检验医学杂志,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
LI Qiao,ZHANG Li-yu,ZHAO Chuan-mei,et al.Analysis of Risk Factors of Intravenous Immunoglobulin
in Children with Non-Responsive Kawasaki Disease in Xi’an Area
and Establishment of Its Predictive Scoring System[J].Journal of Modern Laboratory Medicine,2019,34(06):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
[5]黄君华,崔自明,张书婉,等.完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究[J].现代检验医学杂志,2022,37(01):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
HUANG Jun-hua,CUI Zi-ming,ZHANG Shu-wan,et al.Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2022,37(06):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
[6]张俊民,许爱平,赵利平,等.川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究[J].现代检验医学杂志,2022,37(05):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
ZHANG Jun-min,XU Ai-ping,ZHAO Li-ping,et al.Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin[J].Journal of Modern Laboratory Medicine,2022,37(06):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
[7]马飞艳,王 娟,樊 萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(06):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
[8]李月悦a,唐 莉a,朱明跃b.川崎病患儿血清CTRP9 和sCD146 水平表达与冠状动脉损伤的相关性研究[J].现代检验医学杂志,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]
LI Yueyuea,TANG Lia,ZHU Mingyueb.Correlation between the Expression Levels of Serum CTRP9 and sCD146 and Coronary Artery Lesions in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2024,39(06):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]